How common cold, polio, and related viruses start making proteins

IRES-mediated initiation of picornavirus translation

NIH-funded research Suny Downstate Medical Center · NIH-11231707

Researchers are looking at the viral 'start signal' in rhinovirus, poliovirus and related viruses that lets them hijack cell machinery to make viral proteins, with the aim of helping people affected by those infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSuny Downstate Medical Center NIH-funded
Lab location1 site (Brooklyn, United States)
Project IDNIH-11231707 on NIH RePORTER

What this research studies

From a patient's perspective, scientists will examine a special RNA region called the IRES that some viruses use to begin making their proteins without the cell's usual cues. They will use biochemical binding tests, mutation mapping of the viral 5' untranslated region, and cell-based assays to see how viral RNA interacts with host proteins like eIF4G, PCBP2, and GARS. The team will probe which RNA domains are needed to recruit ribosomes and which host factors are essential for that process. This is lab-based molecular research focused on understanding how these human viruses start infections at the molecular level.

Who could benefit from this research

Good fit: This appears to be laboratory research without patient enrollment, so there are no patient candidates for participation.

Not a fit: People seeking immediate clinical treatments or therapies are unlikely to benefit directly from this basic science project in the short term.

Why it matters

Potential benefit: If successful, the work could reveal new molecular targets for antiviral drugs that block how these viruses make their proteins.

How similar studies have performed: Prior laboratory studies have identified some host factors (like eIF4G and PCBP2) involved in IRES function, but the complete mechanism for Type 1 picornavirus IRES-driven initiation remains unclear and this work builds on those findings.

Where this research is happening

Brooklyn, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Treatment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.